| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Cabozantinib-d6 |
Cabozantinib-d6 |
1802168-46-2 |
詳細(xì)
|
| CP-409092 hydrochloride |
CP-409092 HYDROCHLORIDE |
225240-86-8 |
詳細(xì)
|
| c-Met inhibitor 1 |
3-[(2-甲基-2H-吲唑-5-基)硫基]-6-(1-甲基-1H-吡唑-4-基)-1,2,4-三唑并[4,3-B]噠嗪 |
1357072-61-7 |
詳細(xì)
|
| CNDAC hydrochloride |
CNDAC HCL SALT |
134665-72-8 |
詳細(xì)
|
| CDK9-IN-8 |
CDK9-IN-8 |
2105956-51-0 |
詳細(xì)
|
| CJJ300 |
化合物 CJJ300 |
1807631-83-9 |
詳細(xì)
|
| CCR2 antagonist 1 |
CCR2 ANTAGONIST 1 |
1683534-96-4 |
詳細(xì)
|
| CHZ868 |
1895895-38-1 |
1895895-38-1 |
詳細(xì)
|
| Ceanothic acid |
美洲茶酸 |
21302-79-4 |
詳細(xì)
|
| Cavosonstat |
CAVOSONSTAT (N91115) |
1371587-51-7 |
詳細(xì)
|
| CCR6 inhibitor 1 |
2-Pyridinecarboxamide, 4-[4-[[trans-4-[[5-(trifluoromethyl)-2-pyridinyl]amino]cyclohexyl]sulfonyl]phenyl]- |
2437547-04-9 |
詳細(xì)
|
| c-di-AMP disodium |
環(huán)二腺苷酸二鈉鹽 |
2734909-87-4 |
詳細(xì)
|
| Cantuzumab |
|
1204740-23-7 |
詳細(xì)
|
| Certolizumab pegol |
賽妥珠單抗 |
428863-50-7 |
詳細(xì)
|
| CRAC intermediate 1 |
1249343-86-9 |
1249343-86-9 |
詳細(xì)
|
| CDK8-IN-3 |
CDK8-IN-3 |
1884500-15-5 |
詳細(xì)
|
| Cirsimarin |
濱薊黃甙 |
13020-19-4 |
詳細(xì)
|
| CTX-712 |
化合物 CTX-712 |
2144751-78-8 |
詳細(xì)
|
| CLK1-IN-1 |
2123491-32-5 |
2123491-32-5 |
詳細(xì)
|
| Carbonic anhydrase inhibitor 2 |
化合物 CARBONIC ANHYDRASE INHIBITOR 2 |
2758231-43-3 |
詳細(xì)
|
| Cycloartenol |
環(huán)阿屯醇 |
469-38-5 |
詳細(xì)
|
| Camonsertib |
(3-內(nèi))-3-[6-[(3R)-3-甲基-4-嗎啉基]-1-(1H-吡唑-3-基)-1H-吡唑并[3,4-B]吡啶-4-基]-8-氧雜雙環(huán)[3.2.1]辛-3-醇 |
2417489-10-0 |
詳細(xì)
|
| CKK-E12 |
CKK-E12(MD-1) |
1432494-65-9 |
詳細(xì)
|
| Chlordantoin |
氯登妥因 |
5588-20-5 |
詳細(xì)
|
| CEP dipeptide 1 |
CS-2090 |
816432-15-2 |
詳細(xì)
|
| CBB1007 trihydrochloride |
|
2070015-03-9 |
詳細(xì)
|
| Chitinase-IN-2 hydrochloride |
化合物 T10788L |
2070014-83-2 |
詳細(xì)
|
| CaMKII-IN-1 |
3-氯-2-甲基-N-[5,6,7,8-四氫-2-[(2-苯基乙基)氨基]-6-(苯基甲基)吡啶并[4,3-D]嘧啶-4-基]苯磺酰胺 |
1208123-85-6 |
詳細(xì)
|
| Crocetin monomethyl ester |
8,8'-Diapo-ψ,ψ-carotene-8,8'-dioic acid 8-methyl ester |
25368-09-6 |
詳細(xì)
|
| CC-90002 |
|
2085844-54-6 |
詳細(xì)
|
| Caroverine hydrochloride |
1-[2-(DIETHYLAMINO)ETHYL]-3-[(4-METHOXYPHENYL)METHYL]-2(1H)-QUINOXALINONE MONOHYDROCHLORIDE |
55750-05-5 |
詳細(xì)
|
| Cbl-b-IN-3 |
化合物 CBL-B-IN-3 |
2573775-59-2 |
詳細(xì)
|
| CAY10746 |
CAY10746 |
2247240-76-0 |
詳細(xì)
|
| CCT369260 |
化合物 CCT369260 |
2647503-57-7 |
詳細(xì)
|
| Cebranopadol ((1α,4α)stereoisomer) |
863513-93-3 |
863513-93-3 |
詳細(xì)
|
| CHMFL-BMX-078 |
化合物CHMFL-BMX-078 |
1808288-51-8 |
詳細(xì)
|
| CH6953755 |
CH6953755 |
2055918-71-1 |
詳細(xì)
|
| Cathepsin C-IN-5 |
化合物 CATHEPSIN C-IN-5 |
2825567-97-1 |
詳細(xì)
|
| CT1812 |
CT1812 |
1802632-22-9 |
詳細(xì)
|
| CFTR corrector 4 |
CFTR corrector 4 |
1918142-34-3 |
詳細(xì)
|
| Cadonilimab |
卡度尼利單抗 |
2394841-59-7 |
詳細(xì)
|
| Cipralisant (enantiomer) |
化合物 GT-2331 |
223420-11-9 |
詳細(xì)
|
| CXCR7 modulator 2 |
CXCR7 modulator 2 |
2227426-37-9 |
詳細(xì)
|
| Copanlisib dihydrochloride |
Copanlisib |
1402152-13-9 |
詳細(xì)
|
| Crisnatol |
BWA770U |
96389-68-3 |
詳細(xì)
|
| CLP-3094 |
2-[2-(4-氯-苯氧基)-乙基硫基]-1H-苯并咪唑 |
312749-73-8 |
詳細(xì)
|
| (5Z,2E)-CU-3 |
(5Z,2E)-CU-3 |
1815598-71-0 |
詳細(xì)
|
| CDK9-IN-7 |
CDK9-IN-7 |
2369981-71-3 |
詳細(xì)
|
| CV-6209 |
CV 6209 |
100488-87-7 |
詳細(xì)
|
| Cy3 NHS ester |
CYANINE3 NHS ESTER |
1393363-07-9 |
詳細(xì)
|
| Coumberone |
Coumberone |
878019-47-7 |
詳細(xì)
|
| CD80-IN-3 |
CD80-IN-3 |
486449-65-4 |
詳細(xì)
|
| CU-CPT17e |
2109805-75-4 |
2109805-75-4 |
詳細(xì)
|
| Cot inhibitor-2 |
8-氯-4-[(3-氯-4-氟苯基)氨基]-6-[[[1-(1-乙基-4-哌啶)-1H-1,2,3-三唑-4-基]甲基]氨基]-3-喹啉甲腈 |
915363-56-3 |
詳細(xì)
|
| CCR7 Ligand 1 |
Benzamide, 3-[[4-[[(1R)-2,2-dimethyl-1-(5-methyl-2-furanyl)propyl]amino]-1,1-dioxido-1,2,5-thiadiazol-3-yl]amino]-2-hydroxy-N,N,6-trimethyl- |
681514-83-0 |
詳細(xì)
|
| Cirsiliol |
條葉薊素 |
34334-69-5 |
詳細(xì)
|
| CCT365623 hydrochloride |
CCT365623 |
2126136-98-7 |
詳細(xì)
|
| CL2-SN-38 |
CL2-SN38 |
1036969-20-6 |
詳細(xì)
|
| Cyclo(Arg-Gly-Asp-D-Phe-Cys) |
CYCLO (ARG-GLY-ASP-D-PHE-CYS) |
862772-11-0 |
詳細(xì)
|
| CRT0066854 |
化合物 T27089 |
1438881-19-6 |
詳細(xì)
|
| CDK9-IN-1 |
N-[5-[[6-[3-(1,3-二氧代異吲哚-2-基)苯基]嘧啶-4-基]氨基]-2-甲基苯基]甲烷磺酰胺 |
1415559-43-1 |
詳細(xì)
|
| ComplementfactorD-IN-1 |
1386455-76-0 |
1386455-76-0 |
詳細(xì)
|
| Cephaeline dihydrochloride |
鹽酸吐根酚堿 |
5853-29-2 |
詳細(xì)
|
| Chrysin-7-O-glucuronide |
白楊素-7-0-Β-D-葡萄糖醛酸苷 |
35775-49-6 |
詳細(xì)
|
| CSF1R-IN-3 |
化合物 CSF1R-IN-3 |
2760584-90-3 |
詳細(xì)
|
| Cibisatamab |
賽必妥單抗 |
1855925-27-7 |
詳細(xì)
|
| CCR6 antagonist 1 |
CCR6拮抗劑1 |
588674-64-0 |
詳細(xì)
|
| Cjoc42 |
化合物CJOC42 |
2171519-89-2 |
詳細(xì)
|
| CYM50179 |
CYM50179 |
1355026-47-9 |
詳細(xì)
|
| Calcitonin (8-32), salmon |
VAL-LEU-GLY-LYS-LEU-SER-GLN-GLU-LEU-HIS-LYS-LEU-GLN-THR-TYR-PRO-ARG-THR-ASN-THR-GLY-SER-GLY-THR-PRO-NH2 |
155069-90-2 |
詳細(xì)
|
| Clopidogrel thiolactone |
2S-氧氯吡格雷(鹽酸鹽) |
1147350-75-1 |
詳細(xì)
|
| CARM1-IN-1 |
1020399-49-8 |
1020399-49-8 |
詳細(xì)
|
| cRIPGBM chloride |
化合物 CRIPGBM CHLORIDE |
2361988-77-2 |
詳細(xì)
|
| CK2/ERK8-IN-1 |
CK2/ERK8-IN-1 |
1085822-09-8 |
詳細(xì)
|
| Cariprazine-d6 |
卡利拉嗪-D6 |
1308278-67-2 |
詳細(xì)
|
| (S)-Ceralasertib |
(S)-CERALASERTIB |
1352226-87-9 |
詳細(xì)
|
| CpG ODN 10101 |
化合物 CPG ODN 10101 |
1234402-77-7 |
詳細(xì)
|
| C527 |
192718-06-2 |
192718-06-2 |
詳細(xì)
|
| Coptisine Sulfate |
硫酸黃連堿 |
1198398-71-8 |
詳細(xì)
|
| Cevipabulin fumarate |
CEVIPABULIN FUMARATE |
849550-67-0 |
詳細(xì)
|
| CC-90001 |
CC90001 |
1403859-14-2 |
詳細(xì)
|
| CKD-519 |
CKD-519 |
1402796-27-3 |
詳細(xì)
|
| Cabazitaxel-d6 |
卡巴他賽-D6 |
1383561-29-2 |
詳細(xì)
|
| Cholesterol-13C2 |
膽固醇-3,4-13C2 |
78887-48-6 |
詳細(xì)
|
| CMPD-39 |
化合物USP30 INHIBITOR 18 |
2242582-40-5 |
詳細(xì)
|
| CDK9-IN-2 |
N2'-(反式-4-氨基環(huán)己基)-5'-氯-N6-[(3-氟苯基)甲基]-[2,4'-聯(lián)吡啶]-2',6-二胺 |
1263369-28-3 |
詳細(xì)
|
| Cedirogant |
4-Piperidineacetic acid, 1-[2,4-dichloro-3-[[7-chloro-5-(trifluoromethyl)-1H-indol-1-yl]methyl]benzoyl]- |
2055496-11-0 |
詳細(xì)
|
| CrBKA |
|
2260810-48-6 |
詳細(xì)
|
| CCW16 |
2-氯-N-[4-(4-甲氧基苯氧基)苯基]-N-(苯基甲基)-乙酰胺 |
2361138-33-0 |
詳細(xì)
|
| Cucurbitacin D |
葫蘆素 D |
3877-86-9 |
詳細(xì)
|
| Corin |
CORIN |
1808113-09-8 |
詳細(xì)
|
| Cilastatin-15N,d3 |
Cilastatin-15N-d3 |
2738376-83-3 |
詳細(xì)
|
| Ceranib-2 |
3-[3-(4-Methoxyphenyl)-1-oxo-2-propen-1-yl]-4-phenyl-2(1H)-quinolinone |
1402830-75-4 |
詳細(xì)
|
| Chebulagic acid |
訶子鞣酸 |
23094-71-5 |
詳細(xì)
|
| CM398 |
化合物 CM398 |
1121931-70-1 |
詳細(xì)
|
| CBP/p300-IN-12 |
|
2738688-57-6 |
詳細(xì)
|
| CHIKV-IN-2 |
5H-Benzocycloheptene-2-carboxamide, N-[4-(1-cyano-1-methylethyl)phenyl]-6,7,8,9-tetrahydro-3-methoxy- |
2361289-44-1 |
詳細(xì)
|
| Cyclic-di-GMP diammonium |
CYCLIC-DI-GMP DIAMMONIUM |
609343-82-0 |
詳細(xì)
|
| Cotosudil |
化合物 COTOSUDIL |
1258833-31-6 |
詳細(xì)
|
| Cofrogliptin |
化合物 COFROGLIPTIN |
1844874-26-5 |
詳細(xì)
|